Related Experiment Video
Updated: Jul 6, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Vaping, lung injury, and mental health Minnesota 2018-2019
Cory Cole1, Terra Wiens1, Joanne Taylor1
1Cory Cole, MPH, is applied epidemiology fellow, MDH, through the Council of State and Territorial Epidemiologists Applied Epidemiology Fellowship Program, Atlanta. Terra Wiens, MPH, is an epidemiologist, MDH. Joanne Taylor, PhD, is with the Epidemic Intelligence Service, Division of Scientific Education and Professional Development, CDC, and MDH. Richard Danila, PhD, is epidemiology program manager, MDH. Paige D'Heilly, MPH, is an epidemiologist, MDH. Jamie Margetta, MPH, is health economics and outcomes researcher, Medtronic. Maria Bye, MPH, is healthcare worker monitoring interview team lead, MDH. Erica Mumm, MPH, is applied epidemiology fellow, MDH, through the Council of State and Territorial Epidemiologists Applied Epidemiology Fellowship Program, Atlanta. Lauren Schwerzler, MPH, RDN, is an epidemiologist, MDH. Roon Makhtal is data abstractor, MDH. Stacy Holzbauer, DVM, MPH, is epidemiology field officer, MDH and Center for Preparedness and Response, CDC. Ruth Lynfield, MD, is state epidemiologist, MDH.
Abstract:
This report describes and contextualizes the high prevalence of mental health conditions (MHC) among Minnesota 2019 EVALI patients by examining the prevalence of MHC and associations between MHC and e-cigarette or vaping product (EVP) use in Minnesota population surveys. Investigators reviewed medical records for 140 EVALI patients to determine history of MHC. History of MHC and EVP use in the general population was estimated using self-reported measures and screening tools from two population-based surveys, the 2019 Minnesota Student Survey (MSS) and the 2018 Minnesota Behavioral Risk Factor Surveillance Survey (MN-BRFSS). Some 64.3% of EVALI patients had an MHC. In both Minnesota population surveys, MHCs were common among people who used EVP. The odds of MHC among youth aged <18 were higher among those who reported current EVP use compared with those did not report EVP use. Similarly, the odds of depression were higher among adults who reported current EVP use compared with those who did not. Clinicians treating patients with EVALI should consider evaluating the need for, and providing indicated referrals to, post-discharge mental health services for their patients.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Inhaled Medications
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

